Back to Glossary
Regulatory Terms Starting With O
3 terms in the O index.
ORANGE BOOK
ORANGE BOOK is a recurring concept across regulatory planning, compliance operations, and global submissions.
Orphan Drug Designation (ODD)
A status granted to drugs intended to treat rare diseases affecting fewer than 200,000 people in the US.
Out of Specification (OOS)
A test result that falls outside the established acceptance criteria or specifications.